Trial intelligence / Profile preview

NAC and Zinc for Radiotherapy-Induced Oral Mucositis

NCT06482034Phase 2Completed

Sponsor
Mansoura University
Start
Jun 2023
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of acetylcysteine and zinc in stomatitis (5 arms), sponsored by Mansoura University. Primary endpoints: Incidence of Radiotherapy-Induced Oral Mucositis, Time to Onset of Oral Mucositis and 1 more. Started Jun 2023; status: completed.

02

Drugs

acetylcysteinezinc
03

Conditions

stomatitis

Beyond the preview

Go deeper on NCT06482034.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06482034.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call